Community Trust & Investment Co. increased its position in Zoetis Inc. (NYSE:ZTS – Get Rating) by 42.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 87,013 shares of the company’s stock after purchasing an additional 25,902 shares during the quarter. Community Trust & Investment Co.’s holdings in Zoetis were worth $12,752,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently made changes to their positions in ZTS. MADDEN SECURITIES Corp purchased a new position in Zoetis during the fourth quarter valued at $165,000. EWG Elevate Inc. bought a new stake in shares of Zoetis in the 4th quarter worth $27,000. Roberts Wealth Advisors LLC increased its holdings in shares of Zoetis by 17.3% in the 4th quarter. Roberts Wealth Advisors LLC now owns 20,292 shares of the company’s stock worth $2,980,000 after purchasing an additional 2,986 shares in the last quarter. American National Bank increased its holdings in shares of Zoetis by 3,737.7% in the 4th quarter. American National Bank now owns 2,034 shares of the company’s stock worth $298,000 after purchasing an additional 1,981 shares in the last quarter. Finally, Norway Savings Bank increased its holdings in shares of Zoetis by 4.4% in the 4th quarter. Norway Savings Bank now owns 3,319 shares of the company’s stock worth $486,000 after purchasing an additional 140 shares in the last quarter. Hedge funds and other institutional investors own 90.23% of the company’s stock.
Zoetis Stock Performance
Shares of ZTS traded down $1.84 during trading hours on Friday, hitting $164.47. The stock had a trading volume of 3,605,103 shares, compared to its average volume of 1,774,735. The company has a debt-to-equity ratio of 1.49, a current ratio of 2.37 and a quick ratio of 1.63. Zoetis Inc. has a 12 month low of $124.15 and a 12 month high of $201.32. The firm has a market capitalization of $76.21 billion, a PE ratio of 36.55, a PEG ratio of 2.53 and a beta of 0.76. The stock has a fifty day moving average price of $165.25 and a 200 day moving average price of $155.26.
Zoetis Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 1st. Stockholders of record on Friday, April 21st will be given a $0.375 dividend. The ex-dividend date is Thursday, April 20th. This represents a $1.50 annualized dividend and a dividend yield of 0.91%. Zoetis’s payout ratio is 33.33%.
Analysts Set New Price Targets
A number of analysts have commented on the company. Barclays lifted their target price on Zoetis from $250.00 to $260.00 and gave the stock an “overweight” rating in a report on Tuesday, February 21st. StockNews.com assumed coverage on Zoetis in a report on Thursday. They issued a “buy” rating for the company. Eight equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $223.83.
Zoetis Company Profile
Zoetis, Inc engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The United States segment is involved in U.S.
- Get a free copy of the StockNews.com research report on Zoetis (ZTS)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Get Rating).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.